Effects of transcranial direct current stimulation (tDCS) at different cortical targets on cognition in obsessive-compulsive disorder (OCD): an exploratory analysis
Transcranial direct current stimulation (tDCS) holds promise as a treatment for obsessive-compulsive disorder (OCD). Patients with OCD show impairment in specific domains of cognitive flexibility and response inhibition. We previously reported that tDCS produced a positive clinical effect on OCD symptoms. Here, we report a secondary analysis of neurocognitive data. In this randomized, double-blind, sham-controlled, crossover, multicenter feasibility study, adults with a diagnosis of OCD according to the diagnostic and statistical manual of mental disorders, fifth edition (DSM-5) received three courses of clinic-based tDCS, targeting the left orbitofrontal cortex (L-OFC), bilateral supplementary motor area (SMA), and sham, randomly allocated and delivered in counterbalanced order. Cognitive assessments were conducted before and 2-h after the first stimulation in each arm. Nineteen adults were recruited. tDCS of both the L-OFC and SMA significantly improved cognitive inflexibility, while sham treatment did not (paired-sample t test, baseline vs. 2-h after stimulation). No significant effect of tDCS was found for motor impulsivity (stop-signal reaction time) in any of the three arms. In a small sample of patients with OCD, a single administration of tDCS to the L-OFC and SMA produced a rapid improvement in cognitive inflexibility but not in motor impulsivity. A definitive randomized, controlled trial of tDCS targeting both the OFC and SMA, including cognitive markers, is indicated.
Authors
- Eduardo Cinosi (ORCID: https://orcid.org/0000-0002-8903-181X)
- Natalie Hall (ORCID: https://orcid.org/0000-0002-3635-7699)
- David Wellsted (ORCID: https://orcid.org/0000-0002-2895-7838)
- Samuel Robin Chamberlain (ORCID: https://orcid.org/0000-0001-7014-8121)
- Matthew Garner (ORCID: https://orcid.org/0000-0001-9481-2226)
- Ibrahim H. Aslan (ORCID: https://orcid.org/0000-0001-7366-9037)
- Naomi Fineberg (ORCID: https://orcid.org/0000-0003-1158-6900)
- Luca Pellegrini (ORCID: https://orcid.org/0000-0002-2855-2865)
- Umberto Albert (ORCID: https://orcid.org/0000-0001-9781-4219)
- Amanda Busby (ORCID: https://orcid.org/0000-0002-0545-0276)
- Trevor William Robbins (ORCID: https://orcid.org/0000-0003-0642-5977)
- Megan Smith (ORCID: https://orcid.org/0000-0002-1482-2350)
- David S. Baldwin (ORCID: https://orcid.org/0000-0003-3343-0907)
Institutions
- University of Hertfordshire (GB)
- University of Trieste (IT)
- University of Cambridge (GB)
- Hertfordshire Partnership University NHS Foundation Trust (GB)
- Isle of Wight NHS Trust (GB)
- Hammersmith Hospital (GB)
- Neuroscience Institute (IT)
- Azienda Sanitaria Universitaria Integrata di Trieste (IT)
- University of Southampton (GB)
- Imperial College London (GB)
Publication Details
- Journal
- International Clinical Psychopharmacology
- Published
- 2025-04-03
- DOI
- https://doi.org/10.1097/yic.0000000000000589
- Citations
- 1
- Primary Topic
- Obsessive-Compulsive Spectrum Disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.31
Funders
- University of Hertfordshire